Dental artificial intelligence company Overjet recently received FDA 501(k) clearance for its Periapical Radiolucency Assist device.
Overjet’s device detects instances of periapical radiolucency on radiographs.
This is Overjet’s fifth FDA clearance, according to a Nov. 9 news release. The clearance makes the company the first and only dental AI provider capable of detecting and outlining instances of periapical radiolucency on radiographs for patients ages 12 and older.
With artificial intelligence still getting its feet wet in the dental industry, DSOs and dental groups are looking at all…
The American Academy of Dental Sleep Medicine has released new guidelines for the use of teledentistry with oral appliance therapy.…
New York City-based Rondah AI, the developer of an AI platform for DSOs, raised $1.8 million during a pre-seed funding…
Comments are closed.